摘要
目的:探讨小儿急性淋巴细胞自血病(ALL)的治疗效果。方法:应用全国小儿ALL诊疗建议(第二次修订草案)治疗43例1-7岁小儿ALL。结果:43例患儿总CR率97.7%,无事故生存(EVS)率:1年为(97.67±2.30)%,2~4年为(95.29±3.25)%,5年以上为(73.53±8.47)%。结论:应用全国小儿ALL诊疗建议(第二次修订革案)治疗1~7岁小儿ALL效果比较好,毒副作用较轻,患儿能够耐受,1~7岁ALL患儿有更多的治愈机会,此方案比较适合我国国情。
Objective: To explore the curative effect of children with acute lymphoblastie leukemia (ALL) . Methods: The National Children ALL Recommend of Diagnosis and Therapy was used to treat 43 children with ALL. Results: The complete remission rate reached 97. 7%, the EFS rates were respectively (97. 67±2. 30)%, (95.29±3. 25)%, (73. 53±8.47)% in 1 year, 2~4 years and 5 years. Conclusion: The effect of applying the National Children ALL Recommend is relatively good, the toxic and side effects of the treatment is relatively slight and tolerable. The results come to a conclusion that the treatment protocol is fit for Chinese children.
出处
《中国妇幼保健》
CAS
北大核心
2007年第3期414-416,共3页
Maternal and Child Health Care of China